Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Medical Disclaimer: This article is intended for educational purposes only and should not be considered medical advice
Alle Produkte werden ausschlielich fr Forschungszwecke verkauft
The compound was designed to provide both high IRAP inhibitory capacity and an improved metabolic stability attributed to the introduction of an -amino acid residue adjacent to the predicted scissile peptide bond
The absence of a defined receptor target means that batch-to-batch consistency in peptide identity and purity is particularly important, because the usual pharmacodynamic markers that guide concentration selection for receptor-targeted peptides are not available for this research tool
Important: BPC-157 and TB-500 are not FDA-approved medications
US$ 26.21
US$ 20.75
US$ 27.00
